Oslo Imaging and Therapy Laboratory (OITL)
Oslo Imaging and Therapy Laboratory (OITL), established in 2021 as part of the research and development division of the Norwegian Medical Cyclotron Center (NMS), is a multidisciplinary custom research organization (CRO) located at Domus Medica at the Institute of Basal Medicine at the University of Oslo (UiO).
Oslo Imaging and Therapy Laboratory (OITL)
Equipped with state-of-the-art instrumentation and extensive cross-disciplinary expertise, OITL offers customized and comprehensive support to both industry and academia in radiopharmaceutical development and advanced multimodal molecular imaging. OITL offers a comprehensive range of services supporting all stages of radiopharmaceutical development, from early-stage discovery to clinical application. Beginning with target identification and validation, our team provides expertise in synthesis, screening and optimization of novel agents designed for both diagnostic and therapeutic applications across multiple research areas including oncology, neurology, cardiology, inflammation and fibrosis.
OITL provides a robust suite of preclinical services to advance radiopharmaceutical research and development. Our services include development and validation of preclinical models, tailored to specific disease areas, ensuring a relevant and reliable research platform to our clients. With various imaging methodologies and modalities, OITL offers support in the characterization of novel radiopharmaceuticals.
Through its integrated approach, OITL serves as a facilitator in translating preclinical research into clinical applications, advancing both diagnostic and therapeutic innovation. We provide a robust infrastructure within our multidisciplinary field, enabling larger industry companies to accelerate their research while also accommodating startup companies. Our multipurpose solutions allow for the execution of diverse projects, and through years of investment, we have developed advanced facilities that offer significant support to pharmaceutical firms. Our services are tailored to meet the specific needs of various stakeholders in the industry, and we take pride in contributing to innovation and progress in research.
Contact info
For more information on OITL services and instruments, please contact:
Syed Nuruddin, PhD (Preclinical Research Manager)
E-mail: syed.nuruddin@syklotronsenteret.no
Cell phone: +47 967 24 073
